Mosunetuzumab and Polatuzumab Vedotin for Untreated Follicular Lymphoma
Clinical trial NCT05410418 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05410418
- Sponsor
- Washington University School of Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-24
- Primary completion
- 2025-09-18
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.